Login / Signup

Exenatide preserves trabecular bone microarchitecture in experimental ovariectomized rat model.

Elmin EminovIsmet HortuLevent AkmanOytun ErbasAltug YavasogluTeksin Cirpan
Published in: Archives of gynecology and obstetrics (2018)
Exenatide may be a candidate for use in the treatment of postmenopausal osteoporosis and anti-inflammatory properties can be attributed this effects.
Keyphrases
  • bone mineral density
  • postmenopausal women
  • anti inflammatory
  • body composition
  • bone loss
  • replacement therapy